Chinua Onyebuchi: Applications Now Open for the European Stroke Master Programme
Chinua Onyebuchi, Specialty Doctor at NHS England, shared on LinkedIn:
”Advancing Stroke Care Through Education: A New Opportunity for Clinicians and Researchers
Stroke remains one of the leading causes of deHematology, Hemostasis, Health, Hemostasis Today, Hemostasis News, Medicine, Thrombosis,
ath and disability worldwide.
Improving outcomes requires more than advances in technology—it requires clinicians and researchers who are equipped with the knowledge, skills, and leadership to translate evidence into practice.
The University of Bern, in partnership with the European Stroke Organisation, has announced applications for the European Stroke Master; a Master of Advanced Studies (MAS) in Stroke Medicine, with registration open from January to August 2027.
This part-time programme (2028–2030) is designed for healthcare professionals working in stroke care and offers comprehensive training across:
- Stroke pathophysiology
- Acute ischaemic and haemorrhagic stroke management
- Primary and secondary prevention
- Neurorehabilitation
- Translational and clinical stroke research
With an international faculty of leading stroke experts, predominantly online delivery, and a three-week on-site component in Switzerland, the programme provides an excellent opportunity to develop advanced expertise while remaining in clinical practice.
As stroke care continues to evolve, investing in postgraduate education is one of the most effective ways to strengthen health systems, improve patient outcomes, and prepare the next generation of stroke specialists.
For clinicians considering a career in stroke medicine, this programme is certainly worth exploring.
Scholarships are also available for eligible applicants.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis